News
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
18h
Health and Me on MSNGLP-1 Weight Loss Drug Effectiveness Increases With This Therapy In Postmenopausal Women: StudyWeight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
Thrive Health Solutions also faces a lawsuit from drugmaker Eli Lilly, for allegedly making false claims about FDA approval when selling compounded version of tirzepatide.
1d
MedPage Today on MSNMenopause Hormone Therapy Users May Lose More on Weight Loss InjectableSAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...
1d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
The late-stage readout suggests that HRS9531 can hold its own against Eli Lilly’s blockbuster GLP-1/GIP agonist Zepbound, ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results